Filariasis: Difference between revisions

	Filariasis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Filariasis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT Scan
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Filariasis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
slides
Images
American Roentgen Ray Society Images of Filariasis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Filariasis
on Filariasis
Filariasis in the news
Blogs on Filariasis
Directions to Hospitals Treating Filariasis
Risk calculators and risk factors for Filariasis

← Older edit

VisualWikitext

Latest revision as of 21:45, 29 July 2020

For patient information, click here.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Synonyms and keywords: Filarial elephantiasis

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Filariasis from other Diseases

Epidemiology and Demographics

Risk factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Treatment

Case Studies

Case #1

Related Chapters

Template:Helminthiases

@@ Line 1: / Line 1: @@
 __NOTOC__
-{{Infobox_Disease |
-  Name           = {{PAGENAME}} |
-  Image          = Filariasis 01.jpg |
-}}
 {{Filariasis}}
-'''For patient information, click [[Filariasis (patient information)|here]]'''
-{{CMG}}
+'''For patient information, click [[Filariasis (patient information)|here]].'''
+{{CMG}}; {{AE}} {{AEL}}
+{{SK}} Filarial elephantiasis
 ==[[Filariasis overview|Overview]]==
 ==[[Filariasis historical perspective|Historical Perspective]]==
+==[[Filariasis classification|Classification]]==
 ==[[Filariasis pathophysiology|Pathophysiology]]==
@@ Line 20: / Line 21: @@
 ==[[Filariasis epidemiology and demographics|Epidemiology and Demographics]]==
+==[[Filariasis risk factors|Risk factors]]==
+==[[Filariasis screening|Screening]]==
 ==[[Filariasis natural history, complications and prognosis|Natural History, Complications and Prognosis]]==
 ==Diagnosis==
-[[Filariasis history and symptoms| History and Symptoms]] | [[Filariasis physical examination | Physical Examination]] | [[Filariasis laboratory findings|Laboratory Findings]] | [[Filariasis other diagnostic studies|Other Diagnostic Studies]]
+[[Filariasis history and symptoms| History and Symptoms]] | [[Filariasis physical examination | Physical Examination]] | [[Filariasis laboratory findings|Laboratory Findings]] | [[Filariasis X ray|Xray]] | [[Filariasis CT scan|CT scan]] | [[Filariasis MRI|MRI]] | [[Filariasis ultrasound|Ultrasound]] | [[Filariasis other imaging findings|Other imaging findings]] | [[Filariasis other diagnostic studies|Other Diagnostic Studies]]
 ==Treatment==
-[[Filariasis medical therapy|Medical Therapy]] | [[Filariasis primary prevention|Primary Prevention]] | [[Filariasis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Filariasis future or investigational therapies|Future or Investigational Therapies]]
+[[Filariasis medical therapy|Medical Therapy]] | [[Filariasis surgery|Surgery]] | [[Filariasis primary prevention|Primary Prevention]] | [[Filariasis secondary prevention|Secondary prevention]] | [[Filariasis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Filariasis future or investigational therapies|Future or Investigational Therapies]]
-===Antimicrobial therapy===
-:* '''Filariasis treatment'''
-::* 1. '''Lymphatic filariasis - Wuchereria bancrofti, Brugia malayi Brugia timori'''<ref name="pmid20739055">{{cite journal| author=Taylor MJ, Hoerauf A, Bockarie M| title=Lymphatic filariasis and onchocerciasis. | journal=Lancet | year= 2010 | volume= 376 | issue= 9747 | pages= 1175-85 | pmid=20739055 | doi=10.1016/S0140-6736(10)60586-7 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20739055  }} </ref><ref name="pmid22632644">{{cite journal| author=Knopp S, Steinmann P, Hatz C, Keiser J, Utzinger J| title=Nematode infections: filariases. | journal=Infect Dis Clin North Am | year= 2012 | volume= 26 | issue= 2 | pages= 359-81 | pmid=22632644 | doi=10.1016/j.idc.2012.02.005 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22632644  }} </ref>
-:::* Preferred regimen: [[Diethylcarbamazine]] 6 mg/day PO qd for 12 days (single dose if patient will continue to live in endemic area or is younger than 9 years old) {{with or without}} [[Albendazole]] 400 mg PO qd
-:::* Alternative regimen: [[Doxycycline]] 200 mg/day for 4 weeks {{withorwithout}} [[Ivermectin]] 150 μg/kg single dose (do not administer [[Ivermectin]] if there's a risk of serious adverse effects in areas where Loa loa is coendemic)
-:::* Note: Do not administer [[Diethylcarbamazine]] where onchocerciasis is endemic due to the risk of causing severe local inflammation in patients with ocular microfilariae.
-::* 2. '''Cutaneous filariasis - Onchocercia volvulus, Loa loa'''<ref name="pmid20739055">{{cite journal| author=Taylor MJ, Hoerauf A, Bockarie M| title=Lymphatic filariasis and onchocerciasis. | journal=Lancet | year= 2010 | volume= 376 | issue= 9747 | pages= 1175-85 | pmid=20739055 | doi=10.1016/S0140-6736(10)60586-7 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20739055  }} </ref><ref name="pmid22632644">{{cite journal| author=Knopp S, Steinmann P, Hatz C, Keiser J, Utzinger J| title=Nematode infections: filariases. | journal=Infect Dis Clin North Am | year= 2012 | volume= 26 | issue= 2 | pages= 359-81 | pmid=22632644 | doi=10.1016/j.idc.2012.02.005 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22632644  }} </ref>
-:::* Preferred regimen (1): [[Doxycycline]] 150 μg/kg single dose
-:::* Preferred regimen (2): ([[Doxycycline]] 100 mg PO qd for 6 weeks {{or}} 200 mg PO qd for 4 weeks) {{then}} [[Ivermectin]] after 4-6 months 150 μg/kg single dose
-:::* Preferred regimen (3): [[Doxycycline]] 200 mg PO qd for 6 weeks {{then}} [[Ivermectin]] after 4-6 months 150 μg/kg single dose
 ==Case Studies==
 [[Filariasis case study one|Case #1]]
-{{Helminthiases}}
-[[ar:فلاريا]]
+==Related Chapters==
-[[de:Filariose]]
+* [[Brugia malayi]]
-[[es:Filariasis]]
+* [[Brugia timori]]
-[[fr:Filariose]]
+* [[Loa loa filaria]]
-[[it:Filariosi]]
+* [[Mansonella ozzardi]]
-[[ms:Penyakit Untut]]
+* [[Mansonella perstans]]
-[[ja:フィラリア]]
+* [[Mansonella streptocerca]]
-[[nl:Filariasis]]
+* [[Onchocerca volvulus]]
-[[pt:Filaríase]]
+* [[Wuchereria bancrofti]]
-[[sk:Vlásovce]]
-[[wa:fiyaires]]
-[[Category:Parasitic diseases]]
+{{Helminthiases}}
-[[Category:Neglected diseases]]
-[[Category:Infectious disease]]
+[[Category:Emergency mdicine]]
 [[Category:Disease]]
+[[Category:Up-To-Date]]
-{{WikiDoc Help Menu}}
+[[Category:Infectious disease]]
-{{WikiDoc Sources}}
+[[Category:Vascular medicine]]
+[[Category:Urology]]
-==References==
+[[Category:Gastroenterology]]
-{{reflist|2}}